Martha Sajatovic, MD
Department of Psychiatry
Case Western Reserve University School of Medicine
Director, Geriatric Psychiatry Research
University Hospitals Case Medical Center
Mark Robert Rosenberg, MD, PhD
President, Behavioral Health Management, PC
THIS PROGRAM WAS ORIGINALLY RELEASED AS A LIVE AUDIOCONFERENCE SERIES BEGINNING ON MAY 2, 2007. IF YOU RECEIVED CME OR CPE CREDIT FOR THE AUDIOCONFERENCE, YOU ARE NOT ELIGIBLE TO RECEIVE CREDIT FOR THIS ONLINE VERSION.
This is the first program in a two-part series.
Bipolar disorder (BPD) is a severe and recurrent condition that affects approximately 2% of the U.S. population—more than 2 million American adults. Experiencing a combination of manic and depressive episodes, persons with BPD often face disruption in their families and careers. This condition causes economic problems significant not only for the patients but also for employers and managed healthcare organizations. Managed care organizations face high BPD treatment costs. Societies and families are strained because of lost productivity, reduced quality of life, and suicide.
This activity addresses ways to achieve stable outcomes in persons with BPD to improve their quality of life while also limiting economic consequences. The personal and economic consequences of BPD misdiagnosis are discussed, along with ways to improve recognition and diagnosis. This program provides insight into the complexity of BPD and numerous treatment options with an emphasis on enhancing patient function and productivity. Program Developer/Facilitator
. Target Audience
Managed Care Medical Directors, Pharmacy Directors, Physicians, and Pharmacists
Upon completion of this educational activity, the participant should be able to:
Describe the losses in productivity and quality of life attributable to bipolar disorder.
Review ways to diagnose bipolar disorder early and appropriately.
Discuss pharmacologic strategies to effectively manage bipolar disorder in working adults.
Outline strategies for cost-effective approaches to managing bipolar disorder.
Martha Sajatovic, MD has received research grants from Bristol-Myers Squibb and Abbott Laboratories, is a consultant for AstraZeneca and GlaxoSmithKline, and has received honoraria from AstraZeneca.
Mark Rosenberg, MD has no financial interests to disclose. Credit Statements
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the National Association of Managed Care Physicians (NAMCP) and Medical Communications Media, Inc. The NAMCP is accredited by the ACCME to provide continuing medical education to physicians.
NAMCP designates this continuing medical education activity for a maximum of 1 AMA PRA Category I credit TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Program Number 221-999-07-050-H01 has been assigned to this program (initial release date July 1, 2007). This program is approved for 1.0 contact hours (0.10 CEUs) in states that recognize ACPE providers. The program is provided at no cost to participants. Participants must pass the post-test with a score of 70% or higher and complete the program evaluation to receive pharmacy CE credit. No partial credit will be given.
Commercial Support Statements
Supported by an educational grant from AstraZeneca.
Please turn off all pop-up blockers.
Click on the “start program” icon. This will bring you to the login/registration page where you will be able to register as a new CMEcorner.com member or update/correct existing registration information. When ready, click on the “continue to program” icon at the bottom of the screen. This will take you to a brief pre-program survey.
The next screen will permit you to check for or download the Flash player required to run this program.
Clicking “start the virtual meeting” will allow you to begin the program presentation. This activity will require approximately 60 minutes to complete.
Upon completion of the program, click on the post-test button to access the post-test and program evaluation. This will bring you to a brief post-program survey.
Instructions for completing and submitting the post-test are provided on the post-test screen. A minimum score of 70% on the post-test is required for a CME/CPE statement of credit. Two attempts are allowed.
©2007, Medical Communications Media, Inc. All Rights Reserved.
None of the contents may be reproduced in any form without prior written permission of the publisher. The opinions expressed in this activity are those of the speakers and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the National Association of Managed Care Physicians or AstraZeneca. Any medications or other diagnostic or treatment procedures discussed by the program speakers should not be utilized by clinicians without evaluation of their patients’ conditions and of possible contraindications or risks, and without a review of any applicable manufacturer’s product information and comparison with the recommendations of other authorities.